Genprex to Present at the RHK Capital 4th Annual Disruptive Growth Conference
AUSTIN, Texas & CAMBRIDGE, Mass.— (August 21, 2019) — Genprex, Inc.(NASDAQ: GNPX), a clinical-stage gene therapy company, today announced that its Chairman and Chief Executive Officer, Rodney Varner, is scheduled to present at the 4thAnnual Disruptive Growth Conference hosted by ReedSmith in New York City on September 4, 2019.
Genprex will present at the 4thAnnual Disruptive Growth Conference as follows:
Date: Wednesday, September 4, 2019
Time: 5:00-5:15 p.m. EDT
Venue: ReedSmith Offices, 599 Lexington Avenue, 22ndFloor, New York City
Room: Presentation Room A/B
The 2019 Disruptive Growth Conference will offer the exclusive opportunity to discover growth companies with disruptive technologies and business models covering the following sectors: communications, consumer, energy/alternative energy, healthcare, industrial, life sciences, natural resources and technology.